Insulin For Pennies? Fact-Checkers Bristle

President Trump says prescription drug prices are falling faster than ever, pointing to new company deals and a fresh website called TrumpRx.gov.

Story Snapshot

Trump announced nine new agreements with major drug companies to lower prescription prices to match the lowest prices paid overseas.
The White House launched TrumpRx.gov, a site offering discounts on commonly used prescription drugs.
Trump claims some drugs are being cut by hundreds of percentage points, including insulin as low as three cents.
Fact-checkers and a Senate Democrat report dispute the scale of the claims, citing rising prices on hundreds of drugs.
Border officials separately report record-low crossings and months without parole releases.

White House Touts New Pricing Deals With Drug Makers

President Trump announced nine new agreements with major pharmaceutical companies in December 2025. The deals promise prescription prices in line with the lowest prices paid by other developed nations, a policy known as most-favored-nation pricing. The White House says this marks the largest step yet toward that goal, a promise Trump made repeatedly throughout his second term.

Trump has framed the effort as urgent relief for families squeezed by high medical costs. In earlier remarks, he said some prescription drug prices would drop “almost immediately” by 30 percent to 80 percent. He later said the TrumpRx.gov launch represented the biggest price reduction in history “by many, many times”.

Specific Drugs Named in Price Cuts

The administration points to concrete examples to back its claims. Pfizer agreed to offer many prescription medicines at major discounts in the United States. A separate fact sheet says insulin prices for low-income and uninsured patients could fall to as low as three cents plus a small fee. Trump has also said Wegovy’s monthly cost would drop sharply under new deals.

At a White House event, Trump said his administration had “slashed the price of dozens of commonly used prescription drugs by differences of 400, 500” percent or more. He has repeated similar figures at multiple events, calling the cuts “tremendous” and comparing them to nothing seen in decades of prior administrations.

Fact-Checkers Push Back on the Scale of Claims

Not everyone agrees the numbers add up. PolitiFact rated an earlier Trump claim about falling drug prices as “Mostly False,” pointing to federal data showing a 0.3 percent price increase during part of his first term. AFP’s fact-checking arm said a widely shared claim that prices fell for the first time since 1967 relied on a narrow measurement and was misleading.

A Senate Democrat minority report released in mid-2026 said drug companies raised prices on 688 prescription drugs since Trump returned to office, including 310 brand-name and 378 generic drugs, with a median increase of 5.5 percent. This does not disprove the new pricing deals announced in December, but it shows the picture is more complicated than “prices are down” suggests.

Why the Numbers Differ So Much

Part of the confusion comes from how drug prices actually work. List prices, the sticker price companies advertise, often differ sharply from net prices, what manufacturers actually collect after rebates paid to insurance middlemen. A Federal Trade Commission staff report found these rebates create a gap that can make prices look higher or lower depending on which number gets reported.

Two thirds of commercial insurance patients and 92 percent of Medicare Part D patients pay costs based on list price, not the discounted net price insurers actually pay. That means new company agreements to lower list prices, like the ones Trump announced, could genuinely help patients even if broader industry data still shows some prices rising elsewhere.

Border Numbers Cited Alongside Drug Price Wins

Trump has paired his drug pricing announcements with border security claims in recent speeches. The House Homeland Security Committee reported that December marked eight straight months of zero parole releases by the Border Patrol, ending the prior administration’s catch-and-release policy. Earlier committee data showed a 94 percent drop in Southwest border apprehensions compared to the year before.

Whether the drug pricing deals deliver savings at the pharmacy counter for every American remains to be seen as the agreements roll out through 2026. The list-price discounts and TrumpRx.gov site represent real, documented policy changes. Conservatives who have long complained about opaque pharmacy middlemen and inflated costs have reason to watch these deals closely as they take effect nationwide.